Suppr超能文献

探讨美国共同临床决策下脑膜炎球菌 B 型疫苗接种对话。

Exploring meningococcal serogroup B vaccination conversations under shared clinical decision-making in the US.

机构信息

GSK, Philadelphia, PA, USA.

Verilogue, Philadelphia, PA, USA.

出版信息

Curr Med Res Opin. 2024 Jul;40(7):1253-1263. doi: 10.1080/03007995.2024.2362924. Epub 2024 Jun 14.

Abstract

OBJECTIVE

In 2019, the United States Advisory Committee on Immunization Practices (ACIP) updated their meningococcal serogroup B (MenB) vaccination recommendation for 16-‍23-year-olds from individual to shared clinical decision-making (SCDM). SCDM recommendations are individually based and informed by a decision process between patients and healthcare providers (HCPs). MenB vaccination among 16-23-year-olds remains low. We examined recorded conversations in which MenB vaccine-related discussions between HCPs and patients/caregivers took place, and how these interactions changed following the updated SCDM recommendation.

METHODS

An analysis of recordings where MenB vaccination was discussed between HCPs and patients (16-‍23 years old)/caregivers was conducted using retrospective anonymized dialogue data (January 2015-October 2022). Shared decision-making strength was measured using a modified OPTION5 framework.

RESULTS

Of 97 included recorded conversations, the average duration was 11.3 min. Within these conversations, MenB disease was discussed for 0.25 min (38.9% of words in total vaccine-preventable diseases discussion) and MenB vaccination was discussed for 1.36 min (60.9% of words in total vaccine discussion), on average. HCPs spoke 78.8% of MenB vaccine-related words and most (99.0%) initiated the MenB vaccination discussion. In 40.2% of recordings, HCPs acknowledged the MenB vaccine without providing a clear recommendation. HCP recommendations often favored MenB vaccination (87.0%) and recommendations were 21.4% stronger post-recommendation change to SCDM. As measured by the modified OPTION5 framework, most recordings did not reflect a high degree of shared decision-making between HCPs and patients/caregivers.

CONCLUSIONS

MenB vaccination discussions were brief, and the degree of shared decision-making was low. Targeted education of HCPs and patients/caregivers may improve MenB vaccination awareness, SCDM implementation, and vaccine uptake.

摘要

目的

2019 年,美国免疫实践咨询委员会(ACIP)更新了其 16-23 岁人群脑膜炎奈瑟菌 B 型(MenB)疫苗接种建议,由个体化决策改为共享临床决策(SCDM)。SCDM 建议基于个体,并由患者和医疗保健提供者(HCP)之间的决策过程提供信息。16-23 岁人群的 MenB 疫苗接种率仍然很低。我们研究了记录在案的 HCP 与患者/照顾者之间进行的 MenB 疫苗相关讨论,并研究了在更新后的 SCDM 建议之后,这些互动发生了怎样的变化。

方法

使用回顾性匿名对话数据(2015 年 1 月至 2022 年 10 月)对 HCP 与患者(16-23 岁)/照顾者之间讨论 MenB 疫苗接种的记录进行了分析。使用改良 OPTION5 框架来衡量共享决策的强度。

结果

在 97 次纳入的记录对话中,平均持续时间为 11.3 分钟。在这些对话中,讨论了 MenB 疾病 0.25 分钟(占总疫苗可预防疾病讨论的 38.9%),讨论了 MenB 疫苗接种 1.36 分钟(占总疫苗讨论的 60.9%)。HCP 讲了 78.8%的 MenB 疫苗相关词汇,并且大多数(99.0%)启动了 MenB 疫苗接种讨论。在 40.2%的记录中,HCP 承认了 MenB 疫苗,但没有提供明确的推荐。HCP 的建议通常倾向于 MenB 疫苗接种(87.0%),并且在建议改为 SCDM 后,建议的强度增加了 21.4%。根据改良 OPTION5 框架衡量,大多数记录并未反映 HCP 与患者/照顾者之间高度的共享决策。

结论

MenB 疫苗接种讨论时间很短,共享决策的程度很低。对 HCP 和患者/照顾者进行有针对性的教育可能会提高 MenB 疫苗接种意识、SCDM 的实施和疫苗接种率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验